Alnylam Expands Hepatic Infectious Disease Pipeline; Adds ALNHDV for the Treatment of Chronic Hepatitis Delta Virus HDV Infection and ALNPDL for the Treatment of Chronic Liver Infections
Bioportfolio,
Company Also Remains on Track to Identify Development Candidate DC for ALNHBV an RNAi Therapeutic in Development for the…